Business Context and Reporting Period
This Form 8-K is filed by Oculus Innovative Sciences, Inc. (not Sonoma Pharmaceuticals, Inc., as noted in the request metadata) on August 5, 2008. The report serves to announce the financial results for the fiscal quarter ended June 30, 2008.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references a press release (Exhibit 99.1) containing the full details of these metrics, but the text of that exhibit is not included in the provided source content.
Material Changes
The filing does not contain data to compare current period performance against prior periods. No specific material changes in financial condition or operations are detailed within the text of this Form 8-K.
Guidance, Outlook, and Risks
The document does not include management commentary, forward-looking guidance, risk factors, or details on contingencies and unusual items. It strictly functions as a notification that the press release regarding the Q2 2008 results has been issued.
Investor Verification Checklist
- Verify the actual financial figures (revenue, net loss, cash position) by reviewing Exhibit 99.1 (the press release dated August 5, 2008), as they are not present in this summary text.
- Confirm the company name is Oculus Innovative Sciences, Inc. and not Sonoma Pharmaceuticals, Inc.
- Check for any subsequent filings or updates regarding the fiscal quarter ended June 30, 2008.